These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 31409639)

  • 1. LOXL2 Upregulates Phosphorylation of Ezrin to Promote Cytoskeletal Reorganization and Tumor Cell Invasion.
    Zhan XH; Jiao JW; Zhang HF; Xu XE; He JZ; Li RL; Zou HY; Wu ZY; Wang SH; Wu JY; Liao LD; Wang JJ; Cheng YW; Zhang K; Neufeld G; Xu LY; Li EM
    Cancer Res; 2019 Oct; 79(19):4951-4964. PubMed ID: 31409639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock protein family B member 1 facilitates ezrin activation to control cell migration in esophageal squamous cell carcinoma.
    Xie YH; Li LY; He JZ; Xu XE; Liao LD; Zhang Q; Xie JJ; Xu LY; Li EM
    Int J Biochem Cell Biol; 2019 Jul; 112():79-87. PubMed ID: 31082616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SMYD3 stimulates EZR and LOXL2 transcription to enhance proliferation, migration, and invasion in esophageal squamous cell carcinoma.
    Zhu Y; Zhu MX; Zhang XD; Xu XE; Wu ZY; Liao LD; Li LY; Xie YM; Wu JY; Zou HY; Xie JJ; Li EM; Xu LY
    Hum Pathol; 2016 Jun; 52():153-63. PubMed ID: 26980013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezrin Ser66 phosphorylation regulates invasion and metastasis of esophageal squamous cell carcinoma cells by mediating filopodia formation.
    Li LY; Xie YH; Xie YM; Liao LD; Xu XE; Zhang Q; Zeng FM; Tao LH; Xie WM; Xie JJ; Xu LY; Li EM
    Int J Biochem Cell Biol; 2017 Jul; 88():162-171. PubMed ID: 28504189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LOXL2-dependent deacetylation of aldolase A induces metabolic reprogramming and tumor progression.
    Jiao JW; Zhan XH; Wang JJ; He LX; Guo ZC; Xu XE; Liao LD; Huang X; Wen B; Xu YW; Hu H; Neufeld G; Chang ZJ; Zhang K; Xu LY; Li EM
    Redox Biol; 2022 Nov; 57():102496. PubMed ID: 36209516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-gene signature from protein-protein interaction network of LOXL2- and actin-related proteins for esophageal squamous cell carcinoma prognosis.
    Zhan XH; Jiao JW; Zhang HF; Li CQ; Zhao JM; Liao LD; Wu JY; Wu BL; Wu ZY; Wang SH; Du ZP; Shen JH; Zou HY; Neufeld G; Xu LY; Li EM
    Cancer Med; 2017 Jul; 6(7):1707-1719. PubMed ID: 28556501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel lysyl oxidase-like 2 alternative splicing isoform, LOXL2 Δe13, in esophageal squamous cell carcinoma.
    Lv GQ; Zou HY; Liao LD; Cao HH; Zeng FM; Wu BL; Xie JJ; Fang WK; Xu LY; Li EM
    Biochem Cell Biol; 2014 Oct; 92(5):379-89. PubMed ID: 25275797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L1CAM drives oncogenicity in esophageal squamous cell carcinoma by stimulation of ezrin transcription.
    Guo JC; Xie YM; Ran LQ; Cao HH; Sun C; Wu JY; Wu ZY; Liao LD; Zhao WJ; Fang WK; Li EM; Xu LY; Schachner M; Xie JJ
    J Mol Med (Berl); 2017 Dec; 95(12):1355-1368. PubMed ID: 28939985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phosphorylation of AKT by lysyl oxidase-like 2 activates the PI3K/AKT signaling pathway to promote proliferation, invasion and metastasis in esophageal squamous carcinoma.
    Fan Z; Liu Y; Liu X; Nian W; Huang X; Yang Q; Hou S; Chen F
    Clin Transl Oncol; 2023 Aug; 25(8):2487-2498. PubMed ID: 36995521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A truncated splice variant of human lysyl oxidase-like 2 promotes migration and invasion in esophageal squamous cell carcinoma.
    Zou HY; Lv GQ; Dai LH; Zhan XH; Jiao JW; Liao LD; Zhou TM; Li CQ; Wu BL; Xu LY; Li EM
    Int J Biochem Cell Biol; 2016 Jun; 75():85-98. PubMed ID: 27063404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lysyl oxidase-like 2 promotes esophageal squamous cell carcinoma cell migration independent of catalytic activity.
    Zou H; Wen B; Li RL; Zhan XH; Jiao JW; Liao LD; Wu BL; Xie WM; Xu LY; Li EM
    Int J Biochem Cell Biol; 2020 Aug; 125():105795. PubMed ID: 32580015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A decision tree-based combination of ezrin-interacting proteins to estimate the prognostic risk of patients with esophageal squamous cell carcinoma.
    He JZ; Wu ZY; Wang SH; Ji X; Yang CX; Xu XE; Liao LD; Wu JY; Li EM; Zhang K; Xu LY
    Hum Pathol; 2017 Aug; 66():115-125. PubMed ID: 28603065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ezrin T567 phosphorylation regulates migration and invasion of ectopic endometrial stromal cells by changing actin cytoskeleton.
    Chen C; Ye C; Xia J; Zhou Y; Wu R
    Life Sci; 2020 Aug; 254():117681. PubMed ID: 32380081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of lncRNA EZR-AS1 with SMYD3 maintains overexpression of EZR in ESCC cells.
    Zhang XD; Huang GW; Xie YH; He JZ; Guo JC; Xu XE; Liao LD; Xie YM; Song YM; Li EM; Xu LY
    Nucleic Acids Res; 2018 Feb; 46(4):1793-1809. PubMed ID: 29253179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A protein complex of LCN2, LOXL2 and MMP9 facilitates tumour metastasis in oesophageal cancer.
    Xia Q; Du Z; Chen M; Zhou X; Bai W; Zheng X; Lin L; Zhao Y; Ding J; Wu Z; Zou H; Wang S; Xu L; Li E; Wu B
    Mol Oncol; 2023 Nov; 17(11):2451-2471. PubMed ID: 37753805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LOXL2 in cancer: regulation, downstream effectors and novel roles.
    Wen B; Xu LY; Li EM
    Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188435. PubMed ID: 32976981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein.
    Liang Y; Chen X; Wu Y; Li J; Zhang S; Wang K; Guan X; Yang K; Bai Y
    Cell Death Differ; 2018 Nov; 25(11):1980-1995. PubMed ID: 29511340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPI network analysis of mRNA expression profile of ezrin knockdown in esophageal squamous cell carcinoma.
    Wu B; Xie J; Du Z; Wu J; Zhang P; Xu L; Li E
    Biomed Res Int; 2014; 2014():651954. PubMed ID: 25126570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor activity modifying protein-3 mediates the protumorigenic activity of lysyl oxidase-like protein-2.
    Brekhman V; Lugassie J; Zaffryar-Eilot S; Sabo E; Kessler O; Smith V; Golding H; Neufeld G
    FASEB J; 2011 Jan; 25(1):55-65. PubMed ID: 20802105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. F806 Suppresses the Invasion and Metastasis of Esophageal Squamous Cell Carcinoma via Downregulating F-Actin Assembly-Related Rho Family Proteins.
    Xie L; Li LY; Zheng D; Xie YM; Xu XE; Tao LH; Liao LD; Xie YH; Cheng YW; Xu LY; Li EM
    Biomed Res Int; 2018; 2018():2049313. PubMed ID: 30327774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.